Extracorporeal Treatment for Lithium Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup
Carregando...
Citações na Scopus
128
Tipo de produção
article
Data de publicação
2015
Editora
AMER SOC NEPHROLOGY
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
DECKER, Brian S.
GOLDFARB, David S.
DARGAN, Paul I.
FRIESEN, Marjorie
GOSSELIN, Sophie
HOFFMAN, Robert S.
LAVERGNE, Valery
NOLIN, Thomas D.
GHANNOUM, Marc
Autor de Grupo de pesquisa
EXTRIP Workgrp
BURDMANN, Emmanuel A.
Editores
Coordenadores
Organizadores
Citação
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, v.10, n.5, p.875-887, 2015
Resumo
The Extracorporeal Treatments in Poisoning Workgroup was created to provide evidence-based recommendations on the use of extracorporeal treatments in poisoning. Here, the EXTRIP workgroup presents its recommendations for lithium poisoning. After a systematic literature search, clinical and toxicokinetic data were extracted and summarized following a predetermined format. The entire workgroup voted through a two-round modified Delphi method to reach a consensus on voting statements. A RAND/UCLA Appropriateness Method was used to quantify disagreement, and anonymous votes were compiled and discussed in person. A second vote was conducted to determine the final workgroup recommendations. In total, 166 articles met inclusion criteria, which were mostly case reports, yielding a very low quality of evidence for all recommendations. A total of 418 patients were reviewed, 228 of which allowed extraction of patient-level data. The workgroup concluded that lithium is dialyzable (Level of evidence=A) and made the following recommendations: Extracorporeal treatment is recommended in severe lithium poisoning (1D). Extracorporeal treatment is recommended if kidney function is impaired and the [Li+] is >4.0 mEq/L, or in the presence of a decreased level of consciousness, seizures, or life- threatening dysrhythmias irrespective of the [Li+] (1D). Extracorporeal treatment is suggested if the [Li+] is >5.0 mEq/L, significant confusion is present, or the expected time to reduce the [Li+] to <1.0 mEq/L is >36 hours (2D). Extracorporeal treatment should be continued until clinical improvement is apparent or [Li+] is <1.0 mEq/L (1D). Extracorporeal treatments should be continued for a minimum of 6 hours if the [Li+] is not readily measurable (1D). Hemodialysis is the preferred extracorporeal treatment (1D), but continuous RRT is an acceptable alternative (1D). The workgroup supported the use of extracorporeal treatment in severe lithium poisoning. Clinical decisions on when to use extracorporeal treatment should take into account the [Li+], kidney function, pattern of lithium toxicity, patient's clinical status, and availability of extracorporeal treatments.
Palavras-chave
Referências
- ACHONG MR, 1975, CAN MED ASSOC J, V112, P868
- Adityanjee, 2005, CLIN NEUROPHARMACOL, V28, P38
- AGARWAL SK, 1993, INT J ARTIF ORGANS, V16, P20
- ALLAIN P, 1973, THERAPIE, V28, P1135
- AMDISEN A, 1969, LANCET, V2, P213
- AMDISEN A, 1988, MED TOXICOL ADV DRUG, V3, P18, DOI 10.1007/BF03259929
- ANANTH J, 1992, LITHIUM, V3, P139
- [Anonymous], 2004, J TOXICOL CLIN TOXIC, V42, P843
- APTE SN, 1983, ANN NEUROL, V13, P453, DOI 10.1002/ana.410130414
- Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
- Bailey AR, 2011, CRIT CARE RESUSC, V13, P120
- Bailey B, 2000, THER DRUG MONIT, V22, P650, DOI 10.1097/00007691-200012000-00002
- Bailey B, 2000, CLIN NEPHROL, V54, P388
- BAZILINSKI N, 1986, INT J ARTIF ORGANS, V9, P5
- Beckmann U, 2001, J TOXICOL-CLIN TOXIC, V39, P393, DOI 10.1081/CLT-100105160
- BEJAR JM, 1985, CLIN NEUROPHARMACOL, V8, P379, DOI 10.1097/00002826-198512000-00010
- BELLOMO R, 1991, CRIT CARE MED, V19, P836, DOI 10.1097/00003246-199106000-00018
- BELLOMO R, 1992, LITHIUM, V3, P245
- Benowitz N, 2011, POISONING DRUG OVERD
- Benson BE, 2013, CLIN TOXICOL, V51, P140, DOI 10.3109/15563650.2013.770154
- Bertaso L., 1993, Acta Anaesthesiologica Italica, V44, P261
- Bilanakis N, 2004, PROG NEURO-PSYCHOPH, V28, P201, DOI 10.1016/S0278-5846(03)00167-2
- Bjarnason NH, 2006, THER DRUG MONIT, V28, P262, DOI 10.1097/01.ftd.0000183386.35018.86
- Borras-Blasco J, 2007, SOUTH MED J, V100, P321, DOI 10.1097/01.smj.0000257619.25995.c4
- Bosak Adam R, 2014, J Med Toxicol, V10, P303, DOI 10.1007/s13181-013-0366-z
- Bosinski T, 1998, AM J EMERG MED, V16, P98, DOI 10.1016/S0735-6757(98)90080-8
- Bosse George M., 1992, Journal of Emergency Medicine, V10, P719, DOI 10.1016/0736-4679(92)90531-W
- Bouchard J, 2014, SEMIN DIALYSIS, V27, P371, DOI 10.1111/sdi.12247
- BOUFFARD Y, 1984, PRESSE MED, V13, P1456
- Branger B, 2000, NEPHROLOGIE, V21, P291
- BROWN EA, 1981, BRIT J CLIN PRACT, V35, P90
- Camacho Pulido JA, 1995, FARM CLIN, V12, P509
- Canan Fatih, 2008, Cases J, V1, P156, DOI 10.1186/1757-1626-1-156
- Lopez JC, 2012, HEMODIAL INT, V16, P407, DOI 10.1111/j.1542-4758.2012.00669.x
- Cavaliere F, 1984, Recenti Prog Med, V75, P877
- Chebrolu SB, 2005, CHINESE MED J-PEKING, V118, P1405
- Chen L, 2010, AUST NZ J PSYCHIAT, V44, P95, DOI 10.3109/00048670903393696
- Christian MR, 2011, CLIN TOXICOL, V49, P540
- Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805
- CLENDENINN NJ, 1982, J TOXICOL-CLIN TOXIC, V19, P341, DOI 10.3109/15563658208992488
- Daly F, 2011, TOXICOLOGY HDB, P260
- Danel V, 2001, JEUR, V14, P134
- De Ridder K, 2002, TIJDSCHR GENEESKD, V58, P769
- Deguigne MB, 2013, CLIN TOXICOL, V51, P243, DOI 10.3109/15563650.2013.782409
- Desatnik P, 1995, Lakartidningen, V92, P643
- Dhondt A, 2005, AM J KIDNEY DIS, V46, pE95, DOI 10.1053/j.ajkd.2005.08.001
- DIAS N, 1973, NEPHRON, V10, P246, DOI 10.1159/000180194
- Diaz de Leon Ponce M, 1983, REV MED I MEX SEGURO, V21, P521
- Dieryck J, 1983, TIJDSCHR GENEESKD, V39, P269
- Dupuis RE, 1996, ANN PHARMACOTHER, V30, P356, DOI 10.1177/106002809603000406
- ELMALLAKH RS, 1987, VET HUM TOXICOL, V29, P143
- Eyer F, 2006, J CLIN PSYCHOPHARM, V26, P325, DOI 10.1097/01.jcp.0000218405.02738.b3
- Favarel-Garrigues B, 1972, Ann Med Psychol (Paris), V1, P253
- FAVIN FD, 1988, J TOXICOL-CLIN TOXIC, V26, P443, DOI 10.3109/15563658809038560
- FENVES AZ, 1984, SOUTHERN MED J, V77, P1472, DOI 10.1097/00007611-198411000-00030
- Fiaccadori E, 2008, NEPHROL DIAL TRANSPL, V24, P329
- FINLEY PR, 1995, CLIN PHARMACOKINET, V29, P172, DOI 10.2165/00003088-199529030-00004
- Fitch K, 2011, RAND UCLA APPROPRIAT
- Fountain J, 2014, TOXINZ
- FRIEDBERG RC, 1991, CLIN CHEM, V37, P1205
- GADALLAH MF, 1988, MINER ELECTROL METAB, V14, P146
- GALLARDO MB, 1988, REV CLIN ESP, V183, P156
- GATELL AA, 1989, REV CLIN ESP, V185, P195
- Geddes JR, 2004, AM J PSYCHIAT, V161, P217, DOI 10.1176/appi.ajp.161.2.217
- Ghannoum M, 2014, CLIN TOXICOL PHILA, V30, P1
- Ghannoum M, 2014, SEMIN DIALYSIS, V27, P362, DOI 10.1111/sdi.12228
- Ghannoum M, 2012, CLIN J AM SOC NEPHRO, V7, P1682, DOI 10.2215/CJN.01940212
- Ghannoum M, 2011, ADV CHRONIC KIDNEY D, V18, P160, DOI 10.1053/j.ackd.2011.01.008
- Ghannoum M, 2010, CLIN TOXICOL, V48, P34, DOI 10.3109/15563650903344785
- Gill J, 2003, PHARMACOTHERAPY, V23, P811, DOI 10.1592/phco.23.6.811.32179
- Giuliani E, 2010, MINERVA ANESTESIOL, V76, P463
- GODDARD J, 1991, BRIT MED J, V302, P1267, DOI 10.1136/bmj.302.6787.1267
- Goodman JW, 2006, SEMIN DIALYSIS, V19, P402, DOI 10.1111/j.1525-139X.2006.00194.x
- Gosselin S, 2014, CLIN TOXICOL, V52, P856, DOI 10.3109/15563650.2014.946994
- GREEN ST, 1985, BRIT MED J, V290, P517, DOI 10.1136/bmj.290.6467.517
- Greller HA, 2011, GOLDFRANKS TOXICOLOG, P142
- GROLEAU G, 1987, AM J EMERG MED, V5, P527, DOI 10.1016/0735-6757(87)90178-1
- Groleau Georgina, 1994, Emergency Medicine Clinics of North America, V12, P511
- GUERIN JM, 1990, ARCH INTERN MED, V150, P920, DOI 10.1001/archinte.1990.00390160160051
- Haghfelt T, 1971, Nord Med, V86, P1465
- Handler J, 2009, J CLIN HYPERTENS, V11, P738, DOI 10.1111/j.1751-7176.2009.00181.x
- HANNA ME, 1990, J CLIN PSYCHOPHARM, V10, P379, DOI 10.1097/00004714-199010000-00027
- HANSEN HE, 1978, Q J MED, V47, P123
- HANSEN HE, 1979, ACTA MED SCAND, V205, P593
- Havle N, 2009, KLIN PSIKOFARMAKOL B, V19, P206
- Hazouard E, 1999, NEPHROL DIAL TRANSPL, V14, P1605, DOI 10.1093/ndt/14.6.1605
- Heinrich TW, 2006, PSYCHOSOMATICS, V47, P264, DOI 10.1176/appi.psy.47.3.264
- de Pablo EH, 2008, AN MED INTERN, V25, P209
- Holubek WJ, 2008, KIDNEY INT, V74, P1327, DOI 10.1038/ki.2008.462
- HUGHES PM, 1984, NEW ZEAL MED J, V97, P23
- HUMBERT G, 1974, SEM HOP PARIS, V50, P509
- Ilagan Michael C, 2002, Del Med J, V74, P263
- JACOBSEN D, 1987, J TOXICOL-CLIN TOXIC, V25, P81, DOI 10.3109/15563658708992615
- JAEGER A, 1993, J TOXICOL-CLIN TOXIC, V31, P429, DOI 10.3109/15563659309000411
- JAEGER A, 1985, J TOXICOL-CLIN TOXIC, V23, P501
- Jenniskens-Bruins J J, 1992, Tijdschr Kindergeneeskd, V60, P76
- JENSEN H, 1975, EUR J CLIN PHARMACOL, V8, P285, DOI 10.1007/BF00567130
- Jensen J P, 1974, Ugeskr Laeger, V136, P1505
- JOSEPHS W, 1988, Intensivmedizin, V25, P241
- Kansagra A, 2010, CRIT CARE MED, V38, pA274
- Kansagra AJ, 2014, AM J THER, V21, pE31, DOI 10.1097/MJT.0b013e3182204feb
- KASAHARA H, 1994, JPN J PSYCHIAT NEUR, V48, P1
- Kayrak M, 2010, CARDIOL J, V17, P404
- Kayrak M, 2010, ANN NONINVAS ELECTRO, V15, P289, DOI 10.1111/j.1542-474X.2010.00366.x
- KELLEHER SP, 1986, ARCH INTERN MED, V146, P1839, DOI 10.1001/archinte.146.9.1839
- Kerbusch T, 2002, PHARMACOL TOXICOL, V90, P243, DOI 10.1034/j.1600-0773.2002.900503.x
- Khasraw M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-131
- Kirschner RI, 2011, CLIN TOXICOL, V49, P515
- Kleinert A, 1991, Pol Tyg Lek, V46, P464
- KONDZIELA JR, 1984, HOSP COMMUNITY PSYCH, V35, P727
- Lai CL, 2000, J FORMOS MED ASSOC, V99, P66
- LANG E, 1974, ACTIV NERV SUPER, V16, P197
- LAVENDER S, 1973, POSTGRAD MED J, V49, P277, DOI 10.1136/pgmj.49.570.277
- Lavergne V, 2014, SEMIN DIALYSIS, V27, P407, DOI 10.1111/sdi.12251
- Lavergne V, 2012, CLIN TOXICOL, V50, P403, DOI 10.3109/15563650.2012.683436
- LAWLER PG, 1986, ANAESTHESIA, V41, P623, DOI 10.1111/j.1365-2044.1986.tb13056.x
- Leblanc M, 1996, AM J KIDNEY DIS, V27, P365, DOI 10.1016/S0272-6386(96)90359-5
- Lee DC, 2013, MEDSCAPE
- Lee YC, 2011, HUM EXP TOXICOL, V30, P528, DOI 10.1177/0960327110377524
- LINAKIS JG, 1989, PHARMACOL TOXICOL, V65, P387, DOI 10.1111/j.1600-0773.1989.tb01194.x
- Lins R, 1980, Ned Tijdschr Geneeskd, V124, P545
- Liu WC, 2001, J INT MED TAIWAN, V12, P241
- Long AN, 2011, J INVEST MED, V59, P372
- Lum G, 2007, LABMEDICINE, V38, P667, DOI 10.1309/CGA4FKTUDK2JWF46
- Lundholm Birgitta, 2010, Lakartidningen, V107, P496
- Mactier R, 2014, AM J KIDNEY DIS, V64, P347, DOI 10.1053/j.ajkd.2014.04.031
- Manor E, 1983, ARCH TOXICOL, V53, P384
- Manto M, 1996, NEUROL RES, V18, P416
- Mardini J, 2014, SEMIN DIALYSIS, V27, P402, DOI 10.1111/sdi.12245
- MARSHALL SM, 1981, DRUG INTEL CLIN PHAR, V15, P598
- MASON RW, 1978, CLIN PHARMACOKINET, V3, P241, DOI 10.2165/00003088-197803030-00004
- MATEER JR, 1982, ANN EMERG MED, V11, P208, DOI 10.1016/S0196-0644(82)80500-3
- McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X
- Meertens JHJM, 2009, EUR J INTERN MED, V20, pE70, DOI 10.1016/j.ejim.2008.07.013
- Megarbane B, 2002, CLIN TOXICOL PHILA, V40, P313
- Meltzer E, 2002, ISRAEL MED ASSOC J, V4, P265
- Meltzer H., 2012, BASIC CLIN PHARM, P501
- Menegueti MG, 2012, INDIAN J CRIT CARE M, V16, P109, DOI 10.4103/0972-5229.99134
- Menghini VV, 2000, AM J KIDNEY DIS, V36, part. no., DOI 10.1053/ajkd.2000.16224
- Meyer JM, 2011, GOODMAN GILMANS PHAR, P417
- Meyer RJ, 2001, AM J KIDNEY DIS, V37, P1044, DOI 10.1016/S0272-6386(05)80022-8
- Mowry JB, 2013, CLIN TOXICOL, V51, P949, DOI 10.3109/15563650.2013.863906
- [National Poisons Information Services NPIS], 2014, TOXB
- Newland KD, 2002, AM J EMERG MED, V20, P67, DOI 10.1053/ajem.2002.29553
- Nishiwaki T, 1996, INT J GYNECOL OBSTET, V52, P191, DOI 10.1016/0020-7292(95)02591-X
- NURNBERGER JI, 1985, J NERV MENT DIS, V173, P316, DOI 10.1097/00005053-198505000-00015
- Oakley PW, 2001, AUST NZ J PSYCHIAT, V35, P833, DOI 10.1046/j.1440-1614.2001.00963.x
- Oakley PW, 2000, J TOXICOL-CLIN TOXIC, V38, P333, DOI 10.1081/CLT-100100941
- OCONNOR J, 1982, NEW ZEAL MED J, V95, P790
- Offerman SR, 2010, CLIN TOXICOL, V48, P443, DOI 10.3109/15563650.2010.482533
- OKUSA MD, 1994, AM J MED, V97, P383, DOI 10.1016/0002-9343(94)90308-5
- Oray NC, 2011, ANADOLU PSIKIYATR DE, V12, P198
- Ouellet G, 2014, SEMIN DIALYSIS, V27, P342, DOI 10.1111/sdi.12238
- PAHOLPAK S, 1989, Journal of the Medical Association of Thailand, V72, P112
- Pandey S, 2008, NEUROL INDIA, V56, P484, DOI 10.4103/0028-3886.44816
- Peces R, 2006, NEFROLOGIA, V26, P372
- Peces R, 2001, NEPHROL DIAL TRANSPL, V16, P1301, DOI 10.1093/ndt/16.6.1301-a
- Pedersen R S, 1976, Ugeskr Laeger, V138, P3325
- Perale L, 2010, J EMERG MED, V38, P502, DOI 10.1016/j.jemermed.2008.02.064
- PERRIER A, 1991, CHEST, V100, P863, DOI 10.1378/chest.100.3.863
- Perrone J, 2014, UPTODATE
- PERROT D, 1982, J TOXICOL CLIN EXPER, V2, P49
- Phillips BD, 2008, THYROID, V18, P651, DOI 10.1089/thy.2008.0263
- Plenge Ulla, 2008, Ugeskr Laeger, V170, P354
- POND SM, 1991, MED J AUSTRALIA, V154, P617
- Porto FHG, 2009, J NEUROL SCI, V277, P172, DOI 10.1016/j.jns.2008.10.010
- Prencipe M, 2013, G ITAL NEFROL, V30
- PRINGUEY D, 1981, AM J PSYCHIAT, V138, P249
- Puhr Joshua, 2008, J Med Toxicol, V4, P170
- Roberts DM, 2014, SEMIN DIALYSIS, V27, P390, DOI 10.1111/sdi.12235
- ROSE SR, 1988, DRUG INTEL CLIN PHAR, V22, P691
- ROSEN PB, 1983, ANN NEUROL, V13, P221, DOI 10.1002/ana.410130232
- Sahin Yildiz T, 2006, ANESTEZI DERGISI, V14, P210
- Satar Salim, 2006, Am J Ther, V13, P404, DOI 10.1097/01.mjt.0000174344.51554.43
- Sato Y, 2013, THYROID, V23, P766, DOI 10.1089/thy.2012.0140
- SAXENA S, 1988, BRIT J PSYCHIAT, V152, P853, DOI 10.1192/bjp.152.6.853
- SCHINDLER BA, 1993, PSYCHOSOMATICS, V34, P521, DOI 10.1016/S0033-3182(93)71828-9
- Schmidt JJ, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-49
- Schmitt C, 2009, THERAPIE, V64, P55, DOI 10.2515/therapie/2009010
- SCOBLE JE, 1990, NEPHROL DIAL TRANSPL, V5, P904, DOI 10.1093/ndt/5.10.904
- Slordal L, 2003, BRIT J CLIN PHARMACO, V55, P413, DOI 10.1046/j.1365-2125.2003.01777.x
- Smith D, 2003, J ROY SOC MED, V96, P590, DOI 10.1258/jrsm.96.12.590
- SMITH SW, 1991, ANN EMERG MED, V20, P536, DOI 10.1016/S0196-0644(05)81610-5
- Sood MM, 2007, CAN MED ASSOC J, V176, P921, DOI 10.1503/cmaj.061057
- Swartz C M, 1995, Ann Clin Psychiatry, V7, P207, DOI 10.3109/10401239509149627
- SWARTZ CM, 1994, J CLIN PHARMACOL, V34, P865, DOI 10.1002/j.1552-4604.1994.tb02053.x
- SZERLIP HM, 1992, AM J NEPHROL, V12, P116, DOI 10.1159/000168430
- Takahashi Tetsuya, 2011, Chudoku Kenkyu, V24, P42
- Talwalkar N C, 1986, J Assoc Physicians India, V34, P597
- Tapolyai M, 2002, NEPHRON, V90, P213, DOI 10.1159/000049045
- TEMTE JL, 1994, JAMA-J AM MED ASSOC, V272, P1723, DOI 10.1001/jama.272.22.1723
- THIEL A, 1993, ACTA PSYCHIAT SCAND, V88, P289, DOI 10.1111/j.1600-0447.1993.tb03459.x
- THORNLEYBROWN D, 1992, ANN INTERN MED, V116, P739, DOI 10.7326/0003-4819-116-9-739
- Timmer RT, 1999, J AM SOC NEPHROL, V10, P666
- Treysman L, 2010, CLIN TOXICOL, V48, P647
- TUNKEL AR, 1988, ARCH INTERN MED, V148, P253, DOI 10.1001/archinte.148.1.253
- Unei H, 2008, YAKUGAKU ZASSHI, V128, P165, DOI 10.1248/yakushi.128.165
- Uzu Takashi, 2001, Journal of the Japan Diabetes Society, V44, P767
- van Bommel EFH, 2000, AM J NEPHROL, V20, P408, DOI 10.1159/000013627
- Vasileiou I, 2011, FUND CLIN PHARMACOL, V25, P48, DOI 10.1111/j.1472-8206.2009.00809.x
- Vermeire S, 2010, ACTA CLIN BELG, V65, P127, DOI 10.1179/acb.2010.025
- Voiculescu A., 1995, Intensivmedizin und Notfallmedizin, V32, P433
- VONHARTITZSCH B, 1972, BMJ-BRIT MED J, V4, P757, DOI 10.1136/bmj.4.5843.757
- WANG S-Y, 1985, Taiwan yixuehui zazhi, V84, P960
- Wanscher M C, 1986, Ugeskr Laeger, V148, P2160
- Waring W Stephen, 2006, Toxicol Rev, V25, P221, DOI 10.2165/00139709-200625040-00003
- White B, 2008, INT J CARDIOL, V125, pE48, DOI 10.1016/j.ijcard.2006.12.051
- WHYBROW PC, 1969, LANCET, V1, P839
- Wilkinson Angela, 2009, Practitioner, V253, P28
- WILSON JHP, 1971, BRIT MED J, V2, P749, DOI 10.1136/bmj.2.5764.749
- Yates C, 2014, SEMIN DIALYSIS, V27, P381, DOI 10.1111/sdi.12227
- ZABANEH RI, 1995, ARTIF ORGANS, V19, P94, DOI 10.1111/j.1525-1594.1995.tb02251.x
- Zallo Atxutegi E, 2008, PSIQUIATRIA BIOL, V15, P56
- ZETIN M, 1981, AM J PSYCHIAT, V138, P1387
- ZINGRAFF J, 1975, NOUV PRESSE MED, V4, P3183